9999999997-16-027632.txt : 20161213 9999999997-16-027632.hdr.sgml : 20161213 20161213164922 ACCESSION NUMBER: 9999999997-16-027632 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20161213 DATE AS OF CHANGE: 20161213 20161213 20161213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 162049467 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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